How Cancer Research UK is finding new targets for advanced prostate cancer
dailyrecord.co.ukThanks to research, more people than ever are surviving their cancer. In the 1970s, just one in four people in the UK survived cancer for 10 years or more.
Today, that figure has doubled. But, we have so much more to do. We need to go further, and faster.Cancer Research UK's pioneering work across the UK, including in Scotland, benefits from the generosity of supporters leaving a gift to Cancer Research UK in their Will.
In fact, legacy gifts fund a third of its research.One of its researchers determined to progress cancer research is Dr Imran Ahmad.Based at the Beatson Institute, Dr Ahmad and his team are exploring why people with advanced prostate cancer can become resistant to treatment and looking for new ways to treat it more effectively.Using state-of-the-art techniques, Dr Ahmad is taking a closer look at the molecular mechanisms and processes that lead to prostate cancer.
He’s looking to develop therapies that can target the key molecules in this process, stopping cancer in its tracks.Dr Ahmad appreciates the generous act of those leaving a gift in their Will to Cancer Research UK: "It is humbling, that people want to see research continue into the disease after their death.
Read more on dailyrecord.co.uk